Fingerprint
Dive into the research topics where Division of Addiction (Pennsylvania Psychiatric Institute) is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Sarah Kawasaki, MD
- Department of Psychiatry and Behavioral Health - Associate Professor
- Division of Addiction (Pennsylvania Psychiatric Institute) - Director
- Department of Medicine - Associate Professor
- Division of General Internal Medicine
- Penn State Neuroscience Institute
Person: Academic
-
Barriers to Buprenorphine Initiation in Patients Using Fentanyl
Kawasaki, S. S., Liebschutz, J. M., Murray-Krezan, C., Switzer, G. E., Nash, S., Jeong, K. & Winstanley, E. L., Jan 2 2026, In: JAMA network open. 9, 1, p. e2552136Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol
Freet, C. S., Shuler, K., Kawasaki, S., Weintraub, E., Greenblatt, A., Kladney, M., Nunes, E., Foster, K. L., Kong, L., Raja-Khan, N., Cleveland, H. H., Grigson, P. S., Bunce, S. C., Brick, T. R. & Nyland, J. E., Dec 2025, In: Addiction Science and Clinical Practice. 20, 1, 89.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site “Subthreshold Opioid Use Disorder Prevention” (STOP) Trial
Rostam-Abadi, Y., Liebschutz, J. M., Subramaniam, G., Stone, R., Appleton, N., Mazel, S., Alexander, K., Brill, S. B., Case, A., Gelberg, L., Gordon, A. J., Hong, H., Incze, M. A., Kawasaki, S. S., Kim, T., Kline, M., Lovejoy, T. I., McCormack, J., Zhang, S. & McNeely, J., Sep 2025, In: Journal of general internal medicine. 40, 12, p. 2906-2915 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process
Jennings, L. K., Lander, L., Lawdahl, T., McClure, E. A., Moreland, A., McCauley, J. L., Haynes, L., Matheson, T., Jones, R., Robey, T. E., Kawasaki, S., Moschella, P., Raheemullah, A., Miller, S., Gregovich, G., Waltman, D., Brady, K. T. & Barth, K. S., Dec 2024, In: Addiction Science and Clinical Practice. 19, 1, 26.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
First Response to Opioids Survey Tool (FROST): Pilot study of a brief screening tool to assess opioid use disorder risk
Mills-Huffnagle, S. L., Morris, C., Kawasaki, S., Waverka, G. E., Hammen, H. A. & Zgierska, A. E., May 2024, In: Journal of Opioid Management. 20, 3, p. 197-207 11 p.Research output: Contribution to journal › Article › peer-review
-
Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States
Shen, C., Thornton, J. D., Li, N., Schaefer, E., Zhou, S., Kawasaki, S., Pameijer, C. & Leslie, D., Feb 2024, In: Oncologist. 29, 2, p. 176-184 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
Weimer, M. B., Herring, A. A., Kawasaki, S. S., Meyer, M., Kleykamp, B. A. & Ramsey, K. S., Nov 1 2023, In: Journal of Addiction Medicine. 17, 6, p. 632-639 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access63 Link opens in a new tab Scopus citations -
COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania
Kawasaki, S. S., Zimmerman, R., Shen, C. & Zgierska, A. E., Dec 2023, In: Journal of Substance Use and Addiction Treatment. 155, 209164.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Disability-Adjusted Life-Years for Drug Overdose Crisis and COVID-19 Are Comparable During the Two Years of Pandemic in the United States
Chen, Q., Griffin, P. M. & Kawasaki, S. S., Jun 2023, In: Value in Health. 26, 6, p. 796-801 6 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Nutritional Status Differs by Prescription Opioid Use among Women of Reproductive Age: NHANES 1999–2018
Hohman, E. E., Corr, T. E., Kawasaki, S., Savage, J. S. & Symons Downs, D., Apr 2023, In: Nutrients. 15, 8, 1891.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations